We are live on
!
Find out more
WA
WestEnd Advisors Portfolio holdings
AUM
$4.14B
1-Year Est. Return
15.99%
This Fund
S&P 500
This Quarter
Est. Return
+3.14%
1 Year Est. Return
+15.99%
3 Year Est. Return
+49.16%
5 Year Est. Return
+46.23%
10 Year Est. Return
+187.39%
AUM
$2.16B
AUM Growth
-$63.1M
(-2.8%)
Cap. Flow
-$113M
Cap. Flow
% of AUM
-5.24%
Top 10 Holdings %
Top 10 Hldgs %
54.16%
Holding
33
New
1
Increased
11
Reduced
20
Closed
1
Top Buys
Top Sells
| 1 |
Capri Holdings
CPRI
|
+$102M |
| 2 |
HCA Healthcare
HCA
|
+$6.97M |
| 3 |
Gilead Sciences
GILD
|
+$6.04M |
| 4 |
Nike
NKE
|
+$5.57M |
| 5 |
Estee Lauder
EL
|
+$4.7M |
Sector Composition
| 1 | Healthcare | 32.17% |
| 2 | Technology | 24.12% |
| 3 | Consumer Discretionary | 20.52% |
| 4 | Communication Services | 10.49% |
| 5 | Consumer Staples | 9.83% |
Similar funds
GCM
SP
ZP
BOK
SHCM
AP
CG
BT
WestEnd Advisors's Q2 2015 Portfolio in Review
As of Q2 2015, WestEnd Advisors held 33 positions worth $2.16B, down 2.8% from $2.22B the previous quarter. Its ten largest holdings account for 54% of the portfolio.
WestEnd Advisors withdrew a net $113M in Q2 2015, closing 1 position and reducing 20 holdings. Its most notable exit was Capri Holdings, an estimated $102M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 30% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, WestEnd Advisors opened a new position in Mastercard worth $54.3M.
- WestEnd Advisors's largest Q2 2015 buy was Mastercard: 580,343 shares worth $54.3M.
- WestEnd Advisors added most to Vanguard FTSE All-World ex-US ETF in Q2 2015, an estimated $219K increase.
- WestEnd Advisors's biggest Q2 2015 reduction was HCA Healthcare, cutting an estimated $6.97M.
- WestEnd Advisors fully exited Capri Holdings in Q2 2015, selling an estimated $102M.
- WestEnd Advisors's ten largest holdings make up 54% of its $2.16B portfolio in Q2 2015.
- WestEnd Advisors opened 1 new position and closed 1 in Q2 2015.
- WestEnd Advisors's portfolio value fell 2.8% quarter-over-quarter to $2.16B.
Based on WestEnd Advisors's 13F filing for Q2 2015, filed 27 Jul 2015.